FTA will hurt pharmaceutical sector

Published: 2009-07-16 07:00:00

Updated: 2009-07-16 07:00:00

The successful conclusion of a free trade pact between Korea and the European Union is expected to deal a blow to the local pharmaceutical industry, according to the Korea Pharmaceutical Manufacturers Association.

Following a newly agreed upon patent system - which will lengthen the licensing ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK